News
So let’s get into it. Here’s everything you need to know to address uncommon UC symptoms and seize back control of your ...
Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda (TAK), ...
Juvenile idiopathic arthritis, older age, and concomitant immunomodulation delay the onset of psoriasiform dermatitis in ...
“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...
Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply agreement with ...
Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis: Dublin, Ireland Saturday, August 9, 2025, 15:00 Hrs [IST] Cosm ...
3d
MedPage Today on MSNIBD Linked to Higher Risk of Lung Disease
Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...
Dawson's Creek actor James van der Beek shares how subtle bowel changes were the first warning sign of his stage 3 colorectal ...
With colorectal cancer on the rise in people under 50, researchers at the University of Illinois Urbana-Champaign are looking ...
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...
More than half of adults with inflammatory bowel disease have at least one psychiatric comorbidity, according to research ...
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results